The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on a wide variety of topics.

The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on biomedical science and clinical practice.

Feb 10, 2021 · Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle ...

Dec 10, 2020 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe ...

Dec 20, 2023 · The editors announce a new Perspective series exploring key ethical questions facing medicine today; the hope is that medical ethics can keep pace with the evolution — and revolutions — in ...

Dec 14, 2022 · To the Editor: Reis et al. (May 5 issue)1 present the results of the TOGETHER platform trial, a large trial of ivermectin in outpatients with Covid-19. The relative risk of hospitalization or prolo...

Mar 29, 2023 · AI in Medicine explores the history and vast potential of artificial intelligence and machine learning across all areas of health care.

Oct 20, 2021 · The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the d...

Jun 25, 2021 · Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment of type 2 diabetes. The efficacy ...

Jul 17, 2024 · Explore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.